RESMED INC — Director's Dealing 2014

Jul 16, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-07-15

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-15	ResMed Common Stock	M	3200	$21.675	Acquired	109854.744	Direct
2014-07-15	ResMed Common Stock	S	3200	$49.22	Disposed	106654.744	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-15	ResMed Common Stock Options	$21.675	M	3200	Disposed	2015-10-01	ResMed Common Stock (3200)	Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vested 1/3 on the anniversary of the grant.